4//SEC Filing
Christmas Patrick J. 4
Accession 0001562180-21-001215
CIK 0001590877other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:25 PM ET
Size
9.4 KB
Accession
0001562180-21-001215
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Christmas Patrick J.
Chief Strategy & Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-12$12.10/sh+4,701$56,882→ 21,073 total - Sale
Common Stock
2021-02-12$49.08/sh−4,701$230,725→ 16,372 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-02-12−4,701→ 6,430 totalExercise: $12.10Exp: 2026-08-17→ Common Stock (4,701 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $49.00 to $49.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The previously granted option, representing a right to purchase a total of 125,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 18, 2017, and the balance vested in equal monthly installments over the 36 months thereafter.
Documents
Issuer
REGENXBIO Inc.
CIK 0001590877
Entity typeother
Related Parties
1- filerCIK 0001521123
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:25 PM ET
- Size
- 9.4 KB